세계의 심장 안전 서비스 시장 보고서(2025년)
Cardiac Safety Services Global Market Report 2025
상품코드 : 1821721
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,482,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,370,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,257,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

심장 안전 서비스 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년에 CAGR은 10.7%를 나타낼 것으로 예측되고 17억 5,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 원격 환자 모니터링, 분산형 임상시험으로의 전환, 희귀의약품 개발 증가, 임상시험 아웃소싱 확대, 환자 중심 접근법에 대한 규제 강조 등에 기인할 수 있습니다. 예측 기간의 주요 동향에는 웨어러블 기술 통합, 심전도(ECG) 기술 발전, 분산형 임상시험, 데이터 표준화 및 상호운용성, 텔레헬스 및 원격 상담, 환자 중심 접근법이 포함됩니다.

향후 5년간 10.7% 성장 전망은 이전 예측 대비 0.2% 소폭 하락한 수치입니다. 이 하락은 주로 미국과 타국 간 관세 영향 때문입니다. 관세 부과로 영국 및 인도에서 수입되는 중앙 집중식 심전도(ECG) 분석 및 QT 연장 위험 평가 서비스 접근이 제한되어 미국 의약품 개발에 상당한 도전이 될 수 있으며, 이는 임상시험 비용 증가로 이어질 수 있습니다. 상호 보복 관세와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 효과는 더욱 광범위하게 나타날 것입니다.

심혈관 질환의 유병률 증가는 심장 안전 서비스 시장 성장을 촉진할 것으로 예상됩니다. 심혈관 질환은 말초동맥질환, 뇌혈관질환, 관상동맥질환을 포함하여 심장과 혈관에 영향을 미치는 다양한 장애를 포함됩니다. 심장 안전 서비스는 심장 건강과 안전을 모니터링하고, 심혈관 질환의 위험 요인이 나타난다는 점에 앞서 이를 식별하는 데 주력합니다. 이는 예방 조치 시행과 사망 위험 감축에 도움이 됩니다. 예를 들어, 옥스포드 대학 출판국이 2023년 3월에 발행한 잡지에 따르면 2020년에 2억명 이상이 말초동맥질환을 앓고 있으며, 2045년에 50% 가까이 증가할 것으로 예측되고 있습니다. 게다가 영국을 거점으로 하는 심장혈관 연구의 자선 단체인 영국 심장 재단(British Heart Foundation)이 2024년 9월에 발표한 데이터에 따르면, 영국에서는 약 760만명이 심장·순환기 질환을 안고 있어, 그 내역은 남성 약 400만명, 여성 약 360만명입니다. 이 질병은 영국의 전체 사망의 약 27%를 차지하며 매년 17만 명 이상 하루에 약 480명이 사망하며, 이는 3분에 한 명이 사망하고 있습니다. 따라서 심혈관 질환의 증가하는 유병률은 심장 안전 서비스 수요를 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Cardiac safety services encompass a range of support dedicated to monitoring and ensuring heart safety throughout various clinical trials and research endeavors. These services aid in the design and execution of trials while maintaining a focus on cardiac safety protocols.

Key services within cardiac safety offerings include ECG or Holter measurements, blood pressure assessments, in vitro cardiac safety evaluations, cardiovascular imaging, real-time telemetry monitoring, central over-reading of ECGs, non-invasive cardiac imaging, physiologic stress testing, and comprehensive QT studies, among others. Holter measurements, for instance, involve the continuous recording of the heart's electrical activity for 24 hours or more, allowing remote monitoring away from medical facilities. The phases involved in these services typically span Phase 1, Phase 2, and Phase 3, primarily utilized by pharmaceutical and biopharmaceutical companies, contract research organizations, as well as academic and research institutes to ensure cardiac safety standards in clinical research and trials.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The cardiac safety services market research report is one of a series of new reports from The Business Research Company that provides cardiac safety services market statistics, including cardiac safety services industry global market size, regional shares, competitors with cardiac safety services market share, detailed cardiac safety services market segments, market trends, and opportunities, and any further data you may need to thrive in the cardiac safety services industry. This cardiac safety services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cardiac safety services market size has grown strongly in recent years. It will grow from $1.06 billion in 2024 to $1.16 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to drug development and clinical trials, regulatory compliance requirements, increased cardiovascular disorders, globalization of clinical trials, focus on personalized medicine.

The cardiac safety services market size is expected to see rapid growth in the next few years. It will grow to $1.75 billion in 2029 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to remote patient monitoring, shift towards decentralized clinical trials, rise in orphan drug development, increasing outsourcing of clinical trials, regulatory emphasis on patient-centric approaches. Major trends in the forecast period include integration of wearable technologies, advancements in ECG technologies, decentralized clinical trials, data standardization and interoperability, telehealth and remote consultations, patient-centric approaches.

The forecast of 10.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. drug development by restricting access to centralized Electrocardiography(ECG) analysis and QT prolongation risk assessment services imported from the UK and India, potentially increasing clinical trial costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of cardiovascular diseases is expected to drive the growth of the cardiac safety services market. Cardiovascular diseases encompass a range of disorders affecting the heart and blood vessels, including peripheral arterial disease, cerebrovascular disease, and coronary heart disease. Cardiac safety services focus on monitoring heart health and safety, identifying risk factors for cardiovascular diseases before they manifest, which aids in implementing preventative measures and reducing mortality risk. For example, a journal published by Oxford University Press in March 2023 reported that over 200 million people were affected by peripheral artery diseases in 2020, with projections suggesting a nearly 50% increase by 2045. Additionally, data from the British Heart Foundation, a UK-based cardiovascular research charity, indicated in September 2024 that approximately 7.6 million people in the UK are living with heart and circulatory diseases, comprising about 4 million men and 3.6 million women. These conditions account for around 27% of all deaths in the UK, resulting in over 170,000 fatalities each year, or about 480 deaths per day, which translates to one death every three minutes. Thus, the increasing prevalence of cardiovascular diseases is fueling the demand for cardiac safety services.

The increasing aging population is anticipated to drive the growth of the cardiac safety services market. The term "aging population" refers to the rising median age within a population, attributed to declining fertility rates and increased life expectancy. As this demographic ages, the prevalence of cardiovascular diseases tends to rise, leading to a greater demand for cardiac safety services. Older individuals require specialized care and management for geriatric syndromes within cardiac intensive care units, which can significantly benefit from these services. For example, a report from the Population Reference Bureau, a U.S.-based nonprofit organization, indicated in January 2024 that the number of Americans aged 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050, representing a 47% growth. Additionally, the proportion of this age group within the overall population is expected to rise from 17% to 23% during the same timeframe. Therefore, the growing aging population is fueling the expansion of the cardiac safety services market.

Innovations in product offerings stand as a pivotal trend gaining momentum within the cardiac safety services market. Notably, prominent market players are dedicated to crafting novel solutions to fortify their market presence. For instance, in March 2022, CATHI, a Germany-based technology-driven company, unveiled the CATHIS RHC 2, an updated version of their Right Heart Catheter (RHC) simulator. This improved model retains the original simulator's features and includes additional benefits such as wire-assisted navigation and compatibility with real liquids (S-HUB), enabling the performance of thermodilution.

Major companies operating in the cardiac safety services sector are leveraging advancements such as AI and ML-powered cardiac safety tools to gain a competitive edge. These tools utilize electrocardiogram (ECG) data to furnish detailed insights into continuous ECG data, assessing its quality and accuracy. Notably, Clario, a US-based healthcare company, introduced its AI-powered ECG quality score tool in November 2023. This tool employs machine learning and artificial intelligence to enhance cardiac safety data quality, enabling sponsors to proactively address any anomalies in the data and potentially allowing waivers for conventional Thorough QT (TQT) investigations. The integration of AI technology enhances Clario's Early Precision QT (EPQT) early phase solution, elevating data quality assurance in cardiac safety assessments.

In October 2023, Motion Equity Partners, a private equity firm based in France, acquired Banook Group for an undisclosed sum. This acquisition is intended to boost Banook Group's growth potential and extend its market presence by utilizing Motion Equity Partners' expertise and resources to foster innovation and improve operational efficiencies within the company. Banook Group is a technology company located in France that focuses on providing digital solutions and services for the media and telecommunications industries.

Major companies operating in the cardiac safety services market include Laboratory Corporation of America Holdings, Banook Group Limited, Pharmaceutical Product Development LLC, Biotrial S.A., Certara Inc., Celerion Inc., Medpace Holdings Inc., Ncardia AG, Richmond Pharmacology Limited, PhysioStim, SGS Societe Generale de Surveillance SA, Koninklijke Philips N.V., Clario, NEXEL Co. Ltd., Eurofins Scientific SE, InBody USA Inc., Spaulding Clinical Research LLC, OMRON Healthcare Inc., ERT Inc., IQVIA Holdings Inc., Bioclinica Inc., ICON plc, BioTelemetry Inc., Medidata Solutions Inc., SYNEXUS Clinical Research, PPD Inc., Parexel International Corporation, Chiltern International Limited, ACI Clinical Inc., Biomedical Systems, High Point Clinical Trials Center, Maastricht University Medical Centre+, CCBR-SYNARC, Cytel Inc., CardioSecur Ltd., Medicalgorithmics S.A., Advarra Inc.

North America was the largest region in the cardiac safety services market in 2024. The regions covered in the cardiac safety services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the cardiac safety services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cardiac safety services market includes revenues earned by companies by providing cardiac safety monitoring, ventricular arrhythmias, and cardiovascular performance services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cardiac Safety Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cardiac safety services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for cardiac safety services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac safety services market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Cardiac Safety Services Market Characteristics

3. Cardiac Safety Services Market Trends And Strategies

4. Cardiac Safety Services Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Cardiac Safety Services Growth Analysis And Strategic Analysis Framework

6. Cardiac Safety Services Market Segmentation

7. Cardiac Safety Services Market Regional And Country Analysis

8. Asia-Pacific Cardiac Safety Services Market

9. China Cardiac Safety Services Market

10. India Cardiac Safety Services Market

11. Japan Cardiac Safety Services Market

12. Australia Cardiac Safety Services Market

13. Indonesia Cardiac Safety Services Market

14. South Korea Cardiac Safety Services Market

15. Western Europe Cardiac Safety Services Market

16. UK Cardiac Safety Services Market

17. Germany Cardiac Safety Services Market

18. France Cardiac Safety Services Market

19. Italy Cardiac Safety Services Market

20. Spain Cardiac Safety Services Market

21. Eastern Europe Cardiac Safety Services Market

22. Russia Cardiac Safety Services Market

23. North America Cardiac Safety Services Market

24. USA Cardiac Safety Services Market

25. Canada Cardiac Safety Services Market

26. South America Cardiac Safety Services Market

27. Brazil Cardiac Safety Services Market

28. Middle East Cardiac Safety Services Market

29. Africa Cardiac Safety Services Market

30. Cardiac Safety Services Market Competitive Landscape And Company Profiles

31. Cardiac Safety Services Market Other Major And Innovative Companies

32. Global Cardiac Safety Services Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cardiac Safety Services Market

34. Recent Developments In The Cardiac Safety Services Market

35. Cardiac Safety Services Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기